# Security National Financial Corp: financial statements, quarterly

SNFCA · Nasdaq · CIK 318673 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/snfca.md) · [Financials](/companies/snfca/financials.md) · [Filings](/companies/snfca/filings.md) · [Insiders](/companies/snfca/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snfca/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [80.2](/filings/0001493152-24-045535.md) | [74.9 d](/filings/0001641172-25-001508.md) | [81.2](/filings/0001641172-25-010568.md) | [85.8](/filings/0001641172-25-023791.md) | [88.3](/filings/0001493152-25-022216.md) | [79.3 d](/filings/0001493152-26-010228.md) | [82.7](/filings/0001493152-26-022202.md) | [89.5](/filings/0001493152-26-036814.md) | [89.3](/filings/0001493152-25-022216.md) | [83.0 d](/filings/0001493152-26-010228.md) | [79.7](/filings/0001493152-26-022202.md) | [83.9](/filings/0001493152-26-036814.md) |
| Cost of revenue | $m | [1.2](/filings/0001493152-24-045535.md) | [1.2 d](/filings/0001641172-25-001508.md) | [1.3](/filings/0001641172-25-010568.md) | [1.2](/filings/0001641172-25-023791.md) | [1.1](/filings/0001493152-25-022216.md) | [1.2 d](/filings/0001493152-26-010228.md) | [1.3](/filings/0001493152-26-022202.md) | [1.2](/filings/0001493152-26-036814.md) | [1.1](/filings/0001493152-25-022216.md) | [1.1 d](/filings/0001493152-26-010228.md) | [1.2](/filings/0001493152-26-022202.md) | [1.2](/filings/0001493152-26-036814.md) |
| Interest expense | $m | [1.2](/filings/0001493152-24-045535.md) | [0.8 d](/filings/0001641172-25-001508.md) | [1.0](/filings/0001641172-25-010568.md) | [1.1](/filings/0001641172-25-023791.md) | [1.1](/filings/0001493152-25-022216.md) | [1.1 d](/filings/0001493152-26-010228.md) | [1.1](/filings/0001493152-26-022202.md) | [1.3](/filings/0001493152-26-036814.md) | [1.1](/filings/0001493152-25-022216.md) | [1.0 d](/filings/0001493152-26-010228.md) | [1.0](/filings/0001493152-26-022202.md) | [1.1](/filings/0001493152-26-036814.md) |
| Income tax | $m | [1.1](/filings/0001493152-24-045535.md) | [(1.5) d](/filings/0001641172-25-001508.md) | [2.1](/filings/0001641172-25-010568.md) | [2.1](/filings/0001641172-25-023791.md) | [3.4](/filings/0001493152-25-022216.md) | [0.6 d](/filings/0001493152-26-010228.md) | [1.8](/filings/0001493152-26-022202.md) | [2.4](/filings/0001493152-26-036814.md) | [2.3](/filings/0001493152-25-022216.md) | [3.9 d](/filings/0001493152-26-010228.md) | [2.1](/filings/0001493152-26-022202.md) | [2.7](/filings/0001493152-26-036814.md) |
| Net income | $m | [4.0](/filings/0001493152-24-045535.md) | [2.9 d](/filings/0001641172-25-001508.md) | [7.5](/filings/0001493152-25-022216.md) | [7.3](/filings/0001493152-25-022216.md) | [11.8](/filings/0001493152-25-022216.md) | [2.5 d](/filings/0001493152-26-010228.md) | [6.4](/filings/0001493152-26-036814.md) | [8.4](/filings/0001493152-26-036814.md) | [7.8](/filings/0001493152-25-022216.md) | [13.5 d](/filings/0001493152-26-010228.md) | [7.0](/filings/0001493152-26-036814.md) | [9.0](/filings/0001493152-26-036814.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001493152-24-045535.md) | not reported | [0.31](/filings/0001641172-25-010568.md) | [0.29](/filings/0001641172-25-023791.md) | [0.47](/filings/0001493152-25-022216.md) | not reported | [0.25](/filings/0001493152-26-022202.md) | [0.31](/filings/0001493152-26-036814.md) | [0.31](/filings/0001493152-25-022216.md) | not reported | [0.27](/filings/0001493152-26-022202.md) | [0.33](/filings/0001493152-26-036814.md) |
| Basic EPS | $ per share | [0.17](/filings/0001493152-24-045535.md) | not reported | [0.32](/filings/0001641172-25-010568.md) | [0.30](/filings/0001641172-25-023791.md) | [0.48](/filings/0001493152-25-022216.md) | not reported | [0.26](/filings/0001493152-26-022202.md) | [0.32](/filings/0001493152-26-036814.md) | [0.32](/filings/0001493152-25-022216.md) | not reported | [0.28](/filings/0001493152-26-022202.md) | [0.34](/filings/0001493152-26-036814.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [135](/filings/0001493152-24-045535.md) | [127](/filings/0001641172-25-001508.md) | [151](/filings/0001641172-25-010568.md) | [144](/filings/0001641172-25-023791.md) | [171](/filings/0001493152-25-022216.md) | [141](/filings/0001493152-26-010228.md) | [133](/filings/0001493152-26-022202.md) | [79.3](/filings/0001493152-26-036814.md) | [100](/filings/0001493152-25-022216.md) | [102](/filings/0001493152-26-036814.md) | [150](/filings/0001493152-26-022202.md) | [163](/filings/0001493152-26-036814.md) |
| Total assets | $m | [1,414](/filings/0001493152-23-040828.md) | [1,431](/filings/0001641172-25-001508.md) | [1,447](/filings/0001493152-24-019130.md) | [1,461](/filings/0001493152-24-032027.md) | [1,495](/filings/0001493152-24-045535.md) | [1,494](/filings/0001493152-26-010228.md) | [1,524](/filings/0001641172-25-010568.md) | [1,544](/filings/0001641172-25-023791.md) | [1,563](/filings/0001493152-25-022216.md) | [1,562](/filings/0001493152-26-036814.md) | [1,581](/filings/0001493152-26-022202.md) | [1,609](/filings/0001493152-26-036814.md) |
| Total liabilities | $m | [1,116](/filings/0001493152-23-040828.md) | [1,118](/filings/0001641172-25-001508.md) | [1,126](/filings/0001493152-24-019130.md) | [1,135](/filings/0001493152-24-032027.md) | [1,149](/filings/0001493152-24-045535.md) | [1,113](/filings/0001493152-26-010228.md) | [1,178](/filings/0001641172-25-010568.md) | [1,189](/filings/0001641172-25-023791.md) | [1,198](/filings/0001493152-25-022216.md) | [1,151](/filings/0001493152-26-036814.md) | [1,155](/filings/0001493152-26-022202.md) | [1,176](/filings/0001493152-26-036814.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [298](/filings/0001493152-24-045535.md) | [313](/filings/0001493152-26-010228.md) | [320](/filings/0001493152-25-022216.md) | [326](/filings/0001493152-25-022216.md) | [346](/filings/0001493152-25-022216.md) | [382](/filings/0001493152-26-036814.md) | [385](/filings/0001493152-26-036814.md) | [394](/filings/0001493152-26-036814.md) | [365](/filings/0001493152-25-022216.md) | [410](/filings/0001493152-26-036814.md) | [426](/filings/0001493152-26-036814.md) | [433](/filings/0001493152-26-036814.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.2 d](/filings/0001493152-24-045535.md) | [35.5 d](/filings/0001641172-25-001508.md) | [25.1](/filings/0001641172-25-010568.md) | [(17.0) d](/filings/0001641172-25-023791.md) | [26.8 d](/filings/0001493152-25-022216.md) | [22.4 d](/filings/0001493152-26-010228.md) | [9.6](/filings/0001493152-26-022202.md) | [(7.7) d](/filings/0001493152-26-036814.md) | [25.6 d](/filings/0001493152-25-022216.md) | [18.0 d](/filings/0001493152-26-010228.md) | [32.9](/filings/0001493152-26-022202.md) | [4.0 d](/filings/0001493152-26-036814.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001493152-24-045535.md) | [0.3 d](/filings/0001641172-25-001508.md) | [0.3](/filings/0001641172-25-010568.md) | [0.2 d](/filings/0001641172-25-023791.md) | [0.2 d](/filings/0001493152-25-022216.md) | [1.9 d](/filings/0001493152-26-010228.md) | [0.4](/filings/0001493152-26-022202.md) | [0.4 d](/filings/0001493152-26-036814.md) | [0.7 d](/filings/0001493152-25-022216.md) | [0.1 d](/filings/0001493152-26-010228.md) | [0.2](/filings/0001493152-26-022202.md) | [0.3 d](/filings/0001493152-26-036814.md) |
| Share repurchases | $m | [0.3 d](/filings/0001493152-24-045535.md) | [0.0 d](/filings/0001641172-25-001508.md) | [0.0](/filings/0001641172-25-010568.md) | [1.6 d](/filings/0001641172-25-023791.md) | [0.0 d](/filings/0001493152-25-022216.md) | [1.4 d](/filings/0001493152-26-010228.md) | [0.2](/filings/0001493152-26-022202.md) | [1.0 d](/filings/0001493152-26-036814.md) | [0.4 d](/filings/0001493152-25-022216.md) | [0.0 d](/filings/0001493152-26-010228.md) | [0.8](/filings/0001493152-26-022202.md) | [0.6 d](/filings/0001493152-26-036814.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.7](/filings/0001493152-23-040828.md) | [22.7](/filings/0001493152-24-019130.md) | [23.7](/filings/0001493152-24-032027.md) | [24.0](/filings/0001493152-24-045535.md) | [24.1](/filings/0001641172-25-010568.md) | [25.1](/filings/0001641172-25-023791.md) | [25.3](/filings/0001493152-25-022216.md) | [25.7](/filings/0001493152-26-022202.md) | [26.8](/filings/0001493152-26-036814.md) | [25.4](/filings/0001493152-25-022216.md) | [25.5](/filings/0001493152-26-022202.md) | [26.9](/filings/0001493152-26-036814.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,596,665 at 2021-11-01, from the cover of the [10-Q filed 2021-11-15](/filings/0001493152-21-028399.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.